Recombinant Myocastor coypus Ribonuclease pancreatic (RNASE1)

Shipped with Ice Packs
In Stock

Description

Overview of RNASE1

Ribonuclease 1 (RNASE1) is a pyrimidine-specific endoribonuclease that cleaves single-stranded RNA via a two-step catalytic mechanism: (1) formation of a cyclic 2',3'-phosphodiester intermediate and (2) hydrolysis to a 3'-monophosphate product . In Myocastor coypus (nutria), RNASE1 shares structural and functional homology with human and bovine counterparts, featuring four disulfide bonds critical for stability and activity .

Recombinant Production Strategies

Recombinant RNASE1 is typically produced in heterologous systems such as Escherichia coli or HEK293 cells:

Production SystemKey StepsYield & ActivitySource
E. coli (T7 system)Solubilization from inclusion bodies, refolding, cation-exchange/reversed-phase chromatography52–69% recovery of active enzyme Human RNASE1
HEK293 cellsSecretion as glycosylated protein, His-tag purification>90% purity, specific activity >3×10⁶ U/mg Human RNASE1

Key Challenges:

  • Inclusion Body Refolding: Requires redox systems (e.g., glutathione) to restore disulfide bonds .

  • Glycosylation: Impacts enzyme stability and inhibitor affinity; absent in prokaryotic systems .

Catalytic Activity

  • Substrate Specificity: Preferential cleavage after pyrimidine residues (cytidine/uridine) .

  • Inhibition: Sensitive to human placental ribonuclease inhibitor (RI), which binds with 1:1 stoichiometry . Truncation of the N-terminal 7 residues reduces RI affinity and activity by disrupting secondary structures .

Thermodynamic Stability

  • Disulfide Bonds: Essential for maintaining the kidney bean-shaped tertiary structure .

  • Metal Ion Activation: Enhanced by Na⁺/K⁺ ions but inhibited by alkylation of catalytic histidines (His12, His119) .

Therapeutic Applications and Engineering

Though not directly studied in nutria RNASE1, human RNASE1 has been engineered for targeted cytotoxicity:

Fusion Proteins

Fusion ConstructTargetIC₅₀ (μM)SpecificitySource
GnRH-hpRNASE1GnRH receptor-positive cells0.32Induces apoptosis in PC-3, LNCaP
Tat-hpRNASE1Broad cellular uptake0.55Non-specific cytotoxicity

Mechanism: Fusion peptides (e.g., gonadotropin-releasing hormone) enable receptor-specific internalization, enhancing tumor cell targeting .

Nutria-Specific Considerations

While nutria RNASE1 remains uncharacterized, studies on wild Myocastor coypus highlight:

  • Microbiome: Nutria rectal/nasal cavities host β-hemolytic Aeromonas spp. (e.g., A. hydrophila), which carry virulence genes (ast, alt, flaA) but show low antibiotic resistance dissemination potential .

  • Genetic Diversity: South Korean nutria populations exhibit low genetic heterogeneity, suggesting a single founder population .

Research Gaps and Future Directions

  1. Expression Optimization: Evaluate codon usage and refolding protocols for nutria RNASE1 in E. coli or mammalian systems.

  2. Comparative Studies: Assess catalytic efficiency and RI sensitivity relative to human/murine RNASE1 .

  3. Ecological Impact: Investigate RNASE1’s role in nutria RNA metabolism and its interaction with pathogenic microbiomes .

Product Specs

Form
Lyophilized powder. We will ship the available format, but please specify any format requirements when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specifics. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Specify your desired tag type, and we will prioritize its development.
Synonyms
RNASE1; RNS1; Ribonuclease pancreatic; EC 4.6.1.18; RNase 1; RNase A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-128
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Myocastor coypus (Coypu) (Nutria)
Target Names
RNASE1
Target Protein Sequence
SESSAKKFER QHMDSRGSPS TNPNYCNEMM KSRNMTQGRC KPVNTFVHEP LADVQAVCFQ KNVLCKNGQT NCYQSNSNMH ITDCRVTSNS DYPNCSYRTS QEEKSIVVAC EGNPYVPVHF DASVAASA
Uniprot No.

Target Background

Function
Endonuclease that cleaves RNA on the 3' side of pyrimidine nucleotides. Acts on single and double-stranded RNA.
Protein Families
Pancreatic ribonuclease family
Subcellular Location
Secreted.
Tissue Specificity
Pancreas.

Q&A

What is the molecular structure of Myocastor coypus RNASE1?

Myocastor coypus (nutria/coypu) RNASE1 is a secretory ribonuclease belonging to the pancreatic-type RNase A superfamily. The protein consists of 128 amino acids with a molecular weight of approximately 14,267 Da . The primary sequence includes "SESSAKKFER QHMDSRGSPS TNPNYCNEMM KSRNMTQGRC KPVNTFVHEP LADVQAVCFQ KNVLCKNGQT NCYQSNSNMH ITDCRVTSNS DYPNCSYRTS QEEKSIVVAC EGNPYVPVHF DASVAASA" . Like other RNase A family members, it possesses conserved catalytic residues that are essential for its enzymatic activity. Full structural analysis through X-ray crystallography or NMR spectroscopy would be required to determine its three-dimensional configuration, which has not been comprehensively reported in current literature.

What are the optimal expression systems for producing functional recombinant Myocastor coypus RNASE1?

Recombinant Myocastor coypus RNASE1 can be expressed in multiple expression systems, each with particular advantages depending on research requirements:

Expression SystemAdvantagesConsiderationsTypical Yield
E. coliCost-effective, rapid growth, simple protocolsPotential incorrect folding, absence of mammalian post-translational modifications1-5 mg/L culture
YeastBetter protein folding than E. coli, some post-translational modificationsLonger expression time, more complex protocols0.5-2 mg/L culture
BaculovirusSuperior folding, mammalian-like glycosylationHigher cost, technically demanding0.1-1 mg/L culture
Mammalian cell linesNative-like post-translational modifications, proper foldingMost expensive, longest production time, specialized equipment0.05-0.5 mg/L culture

For structural studies requiring high purity and native conformation, mammalian or baculovirus systems are recommended. For preliminary enzymatic studies, E. coli expression may be sufficient. Codon optimization for the expression host and inclusion of appropriate secretion signals can significantly improve yield and folding.

What methodologies are recommended for assessing RNASE1 enzymatic activity in experimental settings?

Several methodologies can be employed to assess the enzymatic activity of recombinant RNASE1:

  • Spectrophotometric assays: Monitoring the hydrolysis of RNA substrates by measuring changes in absorbance at 260 nm as nucleotides are released.

  • Fluorometric assays: Using fluorescently labeled RNA substrates where fluorescence increases upon cleavage.

  • Gel-based assays: Visualizing RNA degradation patterns through electrophoresis to assess site-specific cleavage preferences.

  • Real-time PCR-based methods: Quantifying remaining intact RNA after enzyme treatment.

For comparative studies, researchers should establish standard curves using commercially available RNase standards and ensure consistent experimental conditions (pH, temperature, ionic strength). Based on studies of human RNASE1, optimal activity conditions typically include a pH around 8.0 and physiological temperature (37°C) . Substrate selection should reflect the research question, with options ranging from natural RNA to synthetic substrates like poly(C).

How does Myocastor coypus RNASE1 compare functionally with other mammalian RNASE1 proteins in terms of evolutionary adaptation?

Evolutionary analysis of RNASE1 across mammals reveals interesting functional divergence patterns. While bovine pancreatic RNase A (often used as a reference) appears to function primarily in digestion, human RNASE1 and bovine brain ribonuclease show pronounced functional similarities that suggest roles beyond simple digestion .

Comparative studies indicate that species-specific adaptations in RNASE1 reflect physiological requirements:

  • Digestive function: Ruminants like cattle show multiple RNASE1 copies adapted for gut RNA digestion.

  • Vascular function: Human RNASE1 is primarily expressed in endothelial cells and may regulate extracellular RNA levels affecting hemostasis and inflammation .

  • Adaptive duplications: In Caniformia (dog-like carnivores), independent gene duplications have occurred in multiple families, with divergent tissue expression patterns suggesting functional specialization .

For Myocastor coypus, a semi-aquatic rodent with specialized digestive adaptations, RNASE1 may have evolved specific functional characteristics. Researchers should compare tissue expression patterns, pH optima, substrate preferences, and catalytic efficiencies across species to elucidate these evolutionary adaptations.

What are the key differences in catalytic mechanisms between Myocastor coypus RNASE1 and other characterized mammalian ribonucleases?

While specific information about Myocastor coypus RNASE1 catalytic mechanisms is limited, comparisons with other characterized mammalian ribonucleases can provide valuable insights. The catalytic mechanism of RNase A family members generally involves:

  • Catalytic triad: His12, His119, and Lys41 (numbering based on bovine RNase A) form the catalytic core.

  • Substrate binding pocket: Determines substrate specificity and affects catalytic efficiency.

  • pH dependency: Optimal activity typically occurs at pH 7.5-8.5.

Variations in these features can lead to functional specialization across species. For instance, human RNASE1 shows higher activity against double-stranded RNA compared to bovine RNase A . To determine specific catalytic differences in Myocastor coypus RNASE1, researchers should perform:

  • Site-directed mutagenesis of putative catalytic residues

  • pH-activity profiles under standardized conditions

  • Substrate specificity assays with various RNA types

  • Kinetic parameter determination (Km, kcat, kcat/Km)

  • Inhibition studies using known RNase inhibitors

These analyses would reveal whether nutria RNASE1 possesses unique catalytic properties that reflect its evolutionary adaptation.

How might Myocastor coypus RNASE1 contribute to extracellular RNA processing and what methodologies can detect this function?

Recent research has identified a novel function for human RNASE1 in the biogenesis of extracellular RNA fragments, specifically tRNA halves and Y RNA fragments . To investigate whether Myocastor coypus RNASE1 possesses similar functions, researchers can employ the following methodologies:

  • Cell culture models: Generate RNASE1 knockout cell lines using CRISPR-Cas9 (as described for human RNASE1 ) and compare extracellular RNA profiles.

  • RNA sequencing: Analyze the size distribution and composition of extracellular RNA in the presence and absence of RNASE1.

  • In vitro processing assays: Incubate purified recombinant RNASE1 with candidate RNA substrates (tRNAs, Y RNAs) and analyze cleavage patterns.

  • Northern blot analysis: Detect specific RNA fragments in extracellular fractions using probes targeting regions of interest.

A comprehensive experimental approach would involve:

  • Separation of extracellular vesicular and non-vesicular fractions

  • Quantification of RNA yield from each fraction

  • Size profiling of isolated RNAs

  • Deep sequencing to identify specific RNA species and their cleavage patterns

  • Validation of key findings through targeted assays

Such analyses would determine whether Myocastor coypus RNASE1 functions in extracellular RNA processing, potentially contributing to intercellular communication or immune regulation.

What potential roles might Myocastor coypus RNASE1 play in host-pathogen interactions, particularly considering the nutria's aquatic environment?

Given that nutrias are known to carry zoonotic pathogens including Aeromonas species , investigating RNASE1's role in host-pathogen interactions presents an intriguing research direction. Secreted ribonucleases can potentially function in:

  • Extracellular antimicrobial defense: Degrading pathogen-derived RNA.

  • Immune signaling modulation: Processing nucleic acids that may trigger innate immune receptors.

  • Biofilm disruption: Breaking down extracellular RNA components of bacterial biofilms.

To investigate these potential functions, researchers could employ:

  • Antimicrobial activity assays against relevant pathogens (particularly Aeromonas spp.)

  • Biofilm formation/disruption assays in the presence of RNASE1

  • Immune cell stimulation experiments with RNASE1-treated pathogen components

  • Gene expression analysis of RNASE1 in nutria tissues after pathogen exposure

The semi-aquatic lifestyle of nutrias exposes them to waterborne pathogens, potentially driving unique adaptations in RNASE1 function. Comparing RNASE1 expression between nutrias and related terrestrial rodents might reveal environment-specific adaptations. Additionally, the higher prevalence of fluoroquinolone-resistant and carbapenem-resistant Aeromonas in nutrias raises questions about whether RNASE1 plays a role in bacterial colonization dynamics.

What factors should be considered when designing experiments to compare enzymatic activities of different species' RNASE1 proteins?

When designing comparative experiments for RNASE1 proteins from different species, researchers should consider:

  • Expression system consistency: Use the same expression system for all proteins to avoid system-specific modifications affecting activity.

  • Purification protocol standardization: Employ identical purification methods to ensure comparable purity levels.

  • Buffer composition: Optimize and standardize pH, ionic strength, and potential cofactors.

  • Substrate selection: Choose appropriate substrates that can detect potential differences in specificity.

  • Enzyme concentration determination: Use accurate protein quantification methods (amino acid analysis preferred over spectrophotometric methods).

  • Temperature considerations: Assess activity at both standard (37°C) and species-specific physiological temperatures.

  • Controls: Include established RNase standards (e.g., bovine RNase A) as reference points.

A well-designed experimental matrix would test each enzyme against multiple substrates (single-stranded, double-stranded, structured RNAs) under varying conditions (pH range 6.0-9.0, temperature range 25-42°C) to generate comprehensive activity profiles that reveal species-specific adaptations.

How can researchers address the challenges of measuring RNASE1 activity in complex biological samples?

Measuring RNASE1 activity in complex biological samples presents several challenges, including the presence of endogenous RNase inhibitors, multiple RNases with overlapping activities, and potential matrix effects. Recommended approaches include:

  • Specific antibody-based depletion: Remove RNASE1 using immunoprecipitation to compare activity before and after depletion.

  • Inhibitor profiling: Use selective inhibitors to distinguish between different RNase activities.

  • Zymography techniques: Adapt RNA-containing polyacrylamide gels to visualize RNase activity bands.

  • Recombinant protein standards: Create calibration curves with purified recombinant RNASE1.

  • Sample preprocessing: Develop fractionation methods to separate RNASE1 from other RNases and inhibitors.

For environmental samples (particularly relevant for studying a semi-aquatic species like nutria), researchers should consider:

  • Environmental RNA degradation assessment using environmental DNA (eDNA) techniques

  • Comparison between tissue expression and environmental detection

  • Controls for environmental inhibitors that may mask enzymatic activity

By combining multiple approaches and including appropriate controls, researchers can obtain more reliable measurements of RNASE1 activity in complex biological samples.

How might comparative studies of Myocastor coypus RNASE1 contribute to our understanding of ribonuclease evolution in semi-aquatic mammals?

Comparative studies of RNASE1 across semi-aquatic mammals could provide valuable insights into convergent and divergent evolution in response to aquatic environments. Research approaches should include:

  • Phylogenetic analysis: Compare RNASE1 sequences among semi-aquatic mammals (nutria, beaver, otter) versus terrestrial relatives to identify convergent adaptations.

  • Structural biology: Determine whether semi-aquatic mammals share specific structural adaptations in RNASE1.

  • Expression profiling: Compare tissue-specific expression patterns, particularly in tissues interfacing with the aquatic environment.

  • Functional assays: Test activity under conditions mimicking aquatic environments (varying pH, salinity, temperature).

  • Selection pressure analysis: Calculate dN/dS ratios to identify sites under positive selection that might reflect aquatic adaptation.

The unique ecological niche of nutrias as invasive semi-aquatic rodents presents an opportunity to study how RNASE1 may have adapted to new environmental pressures. Integration of molecular evolution, structural biology, and enzyme kinetics would provide a comprehensive picture of how this important enzyme family has evolved in response to aquatic adaptation.

What methodological approaches could reveal potential roles of RNASE1 in the nutria's adaptation to invasive environments?

As an invasive species across multiple regions , nutrias may face unique immunological and physiological challenges that could drive RNASE1 adaptation. To investigate this possibility, researchers could employ:

  • Population genetics: Compare RNASE1 sequences between native and invasive nutria populations to identify recent selective pressures.

  • Transcriptomics: Analyze differential expression of RNASE1 in response to changing environmental conditions or pathogen exposure.

  • Microbiomic analysis: Correlate RNASE1 expression/activity with gut microbiota composition in different invasive habitats.

  • Ex vivo activity assays: Test RNASE1 activity against pathogens or substrates from invasive range environments.

  • Ecological sampling: Combine environmental DNA detection methods with RNASE1 activity assays from water samples in nutria habitats.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.